Volume 129, Issue 1, Pages (July 2005)

Slides:



Advertisements
Similar presentations
Volume 142, Issue 4, Pages (April 2012)
Advertisements

Volume 127, Issue 4, Pages (October 2004)
Volume 130, Issue 3, Pages (March 2006)
Volume 78, Issue 3, Pages (August 2010)
Volume 132, Issue 5, Pages (May 2007)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
HIV Increases HCV Replication in a TGF-β1–Dependent Manner
Volume 131, Issue 1, Pages (July 2006)
Volume 128, Issue 1, Pages (January 2005)
Volume 151, Issue 6, Pages (December 2016)
Development of Cell-Penetrating Asymmetric Interfering RNA Targeting Connective Tissue Growth Factor  Jihye Hwang, Chanil Chang, Ji Hyun Kim, Chang Taek.
Volume 138, Issue 3, Pages e2 (March 2010)
Volume 132, Issue 4, Pages (April 2007)
Volume 142, Issue 4, Pages e3 (April 2012)
PTF1α/p48 and cell proliferation
P300 Is Elevated in Systemic Sclerosis and Its Expression Is Positively Regulated by TGF-β: Epigenetic Feed-Forward Amplification of Fibrosis  Asish K.
Volume 146, Issue 5, Pages e1 (May 2014)
Volume 125, Issue 6, Pages (December 2003)
Volume 134, Issue 4, Pages (April 2008)
Volume 125, Issue 1, Pages (July 2003)
Volume 137, Issue 4, Pages e5 (October 2009)
Volume 140, Issue 5, Pages (May 2011)
Volume 131, Issue 1, Pages (July 2006)
Activated Leukocyte Cell-Adhesion Molecule (ALCAM) Promotes Malignant Phenotypes of Malignant Mesothelioma  Futoshi Ishiguro, MD, Hideki Murakami, MD,
Volume 129, Issue 2, Pages (August 2005)
Volume 114, Issue 3, Pages (March 1998)
Volume 142, Issue 4, Pages (April 2012)
Volume 138, Issue 5, Pages e2 (May 2010)
Volume 154, Issue 6, Pages (May 2018)
Volume 140, Issue 4, Pages e1 (April 2011)
Volume 142, Issue 3, Pages e2 (March 2012)
Abrogation of the Antifibrotic Effects of Natural Killer Cells/Interferon-γ Contributes to Alcohol Acceleration of Liver Fibrosis  Won–Il Jeong, Ogyi.
Volume 127, Issue 4, Pages (October 2004)
Volume 135, Issue 6, Pages e7 (December 2008)
Volume 127, Issue 1, Pages (July 2004)
Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice  Zhi-Ming.
Volume 137, Issue 1, Pages (July 2009)
Daniel F. Wallace, Lesa Summerville, V. Nathan Subramaniam 
Volume 130, Issue 3, Pages (March 2006)
Volume 135, Issue 3, Pages e3 (September 2008)
Differential Contribution of Dermal Resident and Bone Marrow–Derived Cells to Collagen Production during Wound Healing and Fibrogenesis in Mice  Reiichi.
Volume 15, Issue 6, Pages (June 2007)
Volume 129, Issue 5, Pages (November 2005)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Volume 132, Issue 5, Pages (May 2007)
Profiling Motility Signal-Specific Genes in Primary Human Keratinocytes  Chieh-Fang Cheng, Jianhua Fan, Balaji Bandyopahdhay, Dennis Mock, Shengxi Guan,
Volume 72, Issue 3, Pages (August 2007)
Naoko Kanda, Shinichi Watanabe  Journal of Investigative Dermatology 
Volume 128, Issue 1, Pages (January 2005)
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 127, Issue 3, Pages (September 2004)
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 140, Issue 7, Pages e2 (June 2011)
Volume 85, Issue 2, Pages (January 2014)
Volume 128, Issue 7, Pages (June 2005)
Volume 127, Issue 4, Pages (October 2004)
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Volume 25, Issue 3, Pages (March 2017)
Volume 122, Issue 5, Pages (May 2002)
Volume 20, Issue 3, Pages (March 2012)
Molecular Therapy - Nucleic Acids
John M. Lamar, Vandana Iyer, C. Michael DiPersio 
Volume 10, Issue 6, Pages (December 2004)
MicroRNA-125b Promotes Hepatic Stellate Cell Activation and Liver Fibrosis by Activating RhoA Signaling  Kai You, Song-Yang Li, Jiao Gong, Jian-Hong Fang,
Volume 22, Issue 6, Pages (June 2014)
Volume 18, Issue 3, Pages (March 2010)
Volume 18, Issue 7, Pages (July 2010)
Fertility and Sterility
Glial cell line-derived neurotrophic factor (GDNF) induces hepatic stellate cell (HSC) activation in human HSCs. Gdnf mRNA expression as determined by.
Presentation transcript:

Volume 129, Issue 1, Pages 259-268 (July 2005) Cell Type-Specific Intervention of Transforming Growth Factor β/Smad Signaling Suppresses Collagen Gene Expression and Hepatic Fibrosis in Mice  Yutaka Inagaki, Miwa Kushida, Kiyoshi Higashi, Johbu Itoh, Reiichi Higashiyama, Yun Yu Hong, Norifumi Kawada, Kazuhiko Namikawa, Hiroshi Kiyama, George Bou-Gharios, Tetsu Watanabe, Isao Okazaki, Kazuo Ikeda  Gastroenterology  Volume 129, Issue 1, Pages 259-268 (July 2005) DOI: 10.1053/j.gastro.2005.03.088 Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 1 Schematic representation of recombinant adenoviruses used in this study. In the Ax17COL-NCre adenovirus, Cre recombinase was expressed by a strong tissue-specific COL1A2 enhancer (−17.0 to −15.5 kilobases) linked to the −350 minimal promoter sequence. The potent CAG expression unit, consisting of the cytomegalovirus immediate early enhancer, modified chicken β-actin promoter, and rabbit β-globin polyadenylation signal, was used to drive Cre in a positive control, AxCANCre. AxCALNLYB1 and AxCALNLGFP adenoviruses were also generated to express YB-1 and GFP, respectively, by the CAG unit after the loxP-flanked stuffer sequence had been excised by Cre recombinase. Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 2 Adenovirus-mediated YB-1 expression in activated hepatic stellate cells. CFSC-2G cells were infected for 1 hour with AxCALNLYB1 recombinant adenovirus alone (−) or together with either Ax17COL-NCre (COL) or AxCANCre (CAG) vector in the absence (UNTR) or the presence of 2 ng/mL TGF-β. (A) Whole-cell lysates were prepared and immunoblotted with anti-YB-1 antibodies. (B) The steady-state levels of endogenous COL1A2 mRNA were determined by real-time reverse-transcription polymerase chain reaction. Relative expression levels of COL1A2 mRNA were normalized against those of glyceraldehyde phosphate dehydrogenase mRNA. The values are mean ± SD obtained from 3 independent RNA preparations and are expressed relative to the levels in untreated cells infected with AxCALNLYB1 virus alone. *Significant difference between groups. Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 3 Adenovirus-mediated GFP expression in normal and carbon tetrachloride-treated liver. Mice were injected via the tail vein with saline (A and D) or 5 × 108 50% tissue culture infectious dose each of AxCALNLGFP adenovirus together with either AxCANCre (B and E) or Ax17COL-NCre (C and F). GFP fluorescence was viewed and analyzed by using a confocal laser scanning microscope in normal (A–C; bar = 200 μm) and carbon tetrachloride-treated (D–F; bar= 250 μm) liver tissues. Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 4 Characterization of GFP-expressing cells in carbon tetrachloride-treated liver. (A) GFP fluorescence expressed by the COL1A2 enhancer was observed in nonparenchymal cells within and around the centrilobular necrotic areas (arrows; bar = 25 μm). (B) Immunofluorescence study using anti-α-SMA antibodies indicated the localization of α-SMA (red) in the GFP (green)-expressing activated HSCs (arrows). An arrowhead shows a GFP-expressing parenchymal hepatocyte that is negative for α-SMA staining (bar = 20 μm). Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 5 Cell type-specific GFP expression in carbon tetrachloride-treated fibrotic liver. Mice were chronically treated with repeated carbon tetrachloride injections for 9 weeks. They were injected via the tail vein with 1 × 109 50% tissue culture infectious dose each of AxCALNLGFP adenovirus together with either AxCANCre (A) or Ax17COL-NCre (B and C) after 7 weeks of carbon tetrachloride intoxication and were continuously treated with carbon tetrachloride for a further 2 weeks. The expression of GFP (green) and the localization of α-SMA (red) were analyzed by using a confocal laser scanning microscope. Arrows indicate the GFP (green)-expressing activated HSCs that are positive for α-SMA (red) staining (C) (bar = 100 μm in A and B; bar = 25 μm in C). Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 6 Effects of YB-1 expression on the activation of the COL1A2 promoter. Transgenic reporter mice harboring the COL1A2 upstream sequence linked to a firefly luciferase gene were injected with control saline, 5 × 108 50% tissue culture infectious dose (TCID50) of Ax17COL-NCre adenovirus alone (COL), or 5 × 108 TCID50 each of Ax17COL-NCre and AxCALNLYB-1 (COL/YB-1). Twenty-four hours later, they were treated with a single injection of 1 mL/kg body weight of carbon tetrachloride. Livers were excised 72 hours after carbon tetrachloride injection and subjected to luciferase assays. The values are mean ± SD obtained from 7 mice in each group. Values in the control mice without carbon tetrachloride injection (UNTR) are also presented. *Significant difference between groups. NS, not significant; RLU, relative luminescence units. Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions

Figure 7 Suppressive effects of YB-1 on the progression of hepatic fibrosis. Mice were chronically treated with 1 mL/kg body weight carbon tetrachloride twice a week for 9 weeks. They were injected with either control saline or 5 × 108 50% tissue culture infectious dose each of Ax17COL-NCre and AxCALNLYB1 (COL/YB-1) after 7 weeks of carbon tetrachloride intoxication and continuously treated with carbon tetrachloride for a further 2 weeks. Some mice were treated simultaneously with 10,000 U/day of recombinant murine IFN-γ every day during the last 2 weeks. They were killed 72 hours after the last carbon tetrachloride injection and subjected to (A) real-time reverse-transcription polymerase chain reaction assays quantifying the steady-state levels of COL1A2 and YB-1 mRNA, (B) Western blot analyses to detect type I collagen expression, (C) measurement of serum hyaluronic acid concentration, and (D) Azan-Mallory staining (original magnification, 100×). In the real-time reverse-transcription polymerase chain reaction assays, relative expression levels of COL1A2 and YB-1 mRNA were normalized against those of glyceraldehyde phosphate dehydrogenase mRNA. After Azan-Mallory staining, the degree of hepatic fibrosis was semiquantified by measuring the mean relative areas of fibrosis with the aid of computer software. The values are mean ± SD obtained from 7 mice in each group. *Significant difference between groups. NS, not significant. Gastroenterology 2005 129, 259-268DOI: (10.1053/j.gastro.2005.03.088) Copyright © 2005 American Gastroenterological Association Terms and Conditions